Imagine a spinal fusion technology that not only sets new standards but also redefines how we approach complex surgeries. Enter NanoFUSE Biologics—a groundbreaking innovation from KIC Ventures. 

​

What Makes NanoFUSE Different? 

​

• FDA-Cleared Combination: The first and only bioactive glass product cleared to be combined with demineralized bone matrix (DBM). 

• Dual Functionality: Blends DBM’s osteoinductive properties with bioactive glass’s osteostimulative capabilities for optimal bone growth. 

• Versatile in Surgery: Ideal for cervical and lumbar spine fusions, including interbody cages and posterolateral gutters. 

• Surgeon-Driven Innovation: Collaborations with spine surgeons have led to custom solutions for scoliosis and other complex cases. 

​

​​

​

Real-World Success 

​

NanoFUSE doesn’t just perform—it excels. In preclinical studies, it has shown greater osteoinductive potential compared to DBM or bioactive glass alone, even outperforming other biologic competitors. Surgeons report enhanced fusion results, making it a preferred choice for challenging spinal surgeries. 

​​

​

Why Surgeons Choose NanoFUSE 

• Superior Outcomes: Consistent and reliable bone growth. 

• Synthetic Advantage: Reduces the need for human tissue, making procedures less invasive. 

• Trusted by Experts: Developed in partnership with top spine surgeons to ensure clinical efficacy. 

 

 

Ready to Transform Spinal Surgery? 

​

NanoFUSE Biologics is more than a product—it’s a step forward in spinal care. Discover how it’s changing outcomes for surgeons and patients alike. 

​

To read more and connect with us, visit: KIC Ventures Contact Us